In this issue:
- Realising the promise of HPV vaccination
- Participants experience of HPV primary screening
- Patient-reported outcomes during pelvic radiation therapy
- Avutometinib +/- defactinib in recurrent low-grade serous ovarian cancer
- Nivolumab + ipilimumab in advanced gynaecological clear cell cancers
- Pembrolizumab in advanced gynaecological clear cell cancers
- Ipilimumab and nivolumab in small cell carcinoma of the ovary
- Neoadjuvant chemotherapy in advanced ovarian cancer
- Alpelisib + olaparib in high-grade serous ovarian cancer
- Relacorilant and nab-paclitaxel in platinum-resistant ovarian cancer
Please login below to download this issue (PDF)